(Q54082730)

24 May 2018

title

Prognosis for fludarabine therapy of chronic lymphocytic leukaemia based on ex vivo drug response by DiSC assay. (English)

1 reference

24 May 2018

chronic lymphocytic leukemia

0 references

1 reference

1 reference

Bosanquet AG

1

1 reference

24 May 2018

Johnson SA

series ordinal

2

1 reference

24 May 2018

Richards SM

series ordinal

3

1 reference

24 May 2018

language of work or name

English

0 references

publication date

1 July 1999

1 reference

24 May 2018

British Journal of Haematology

published in

1 reference

24 May 2018

volume

106

1 reference

24 May 2018

issue

1

1 reference

24 May 2018

page(s)

71-77

1 reference

24 May 2018

Correlations between therapeutic response of leukaemias and in-vitro drug-sensitivity assay

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01516.X

Enhanced ex vivo drug sensitivity testing of chronic lymphocytic leukaemia using refined DiSC assay methodology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01516.X

Ex vivo cytotoxic drug evaluation by DiSC assay to expedite identification of clinical targets: results with 8-chloro-cAMP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01516.X

In vitro chemosensitivity of chronic lymphocytic leukaemia to purine analogues--correlation with clinical course

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01516.X

Chlorambucil in indolent chronic lymphocytic leukemia. French Cooperative Group on Chronic Lymphocytic Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01516.X

Phase I/II evaluation of pentostatin (2'-deoxycoformycin) in a five day schedule for the treatment of relapsed/refractory B-cell chronic lymphocytic leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01516.X

In vitro resistance to cytosine arabinoside, not to daunorubicin, is associated with the risk of relapse in de novo acute myeloid leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01516.X

The DiSC assay. A cost-effective guide to treatment for chronic lymphocytic leukemia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01516.X

Cytotoxic Drugs, Programmed Cell Death, and the Immune System: Defining New Roles in an Old Play

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01516.X

10.1046/J.1365-2141.1999.01516.X

21 January 2018

Identifiers

DOI

1 reference

24 May 2018

1 reference

24 May 2018